Granza Bio

Winter 2024Active

Building programmable therapeutics for the immune system

Save

Granza Bio

Winter 2024Active

Building programmable therapeutics for the immune system

Save

Company details

Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.

Location

San Francisco, CA, USA

Founded

Unknown

Request the Granza Bio report.

Granza Bio has no report yet. Sign in with your email to request one.